首页> 美国卫生研究院文献>PLoS Clinical Trials >Factors Affecting Blood Pressure Variability: Lessons Learned from Two Systematic Reviews of Randomized Controlled Trials
【2h】

Factors Affecting Blood Pressure Variability: Lessons Learned from Two Systematic Reviews of Randomized Controlled Trials

机译:影响血压变异性的因素:从两次随机对照试验的系统评价中吸取的教训

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Systematic reviews can often reveal much more than the original objective of the work. The objectives of this retrospective analysis were to answer three basic questions about blood pressure variability: 1) Does blood pressure entry criterion have an effect on baseline blood pressure variability? 2) Do thiazide diuretics have a significant effect on blood pressure variability? and 3) Does systolic blood pressure vary to the same degree as diastolic blood pressure? This analysis of blood pressure variability is based on resting standardized research setting BP readings from two systematic reviews evaluating blood pressure lowering efficacy of thiazide diuretics from double blind randomized controlled trials in 33,611 patients with primary hypertension. The standard deviation reported in trials was the focus of the research and the unit of analysis. When a threshold systolic or diastolic blood pressure value is used to determine entry into a trial, baseline variability is significantly decreased, systolic from 14.0 to 9.3 mmHg and diastolic from 8.4 to 5.3 mmHg. Thiazides do not change BP variability as the standard deviation and coefficient of variation of systolic blood pressure and diastolic blood pressure did not differ between thiazide and placebo groups at end of treatment. The coefficient of variation of systolic blood pressure was significantly greater than the coefficient of variation of diastolic blood pressure. Entry criterion decreases the baseline blood pressure variability. Treatment with a thiazide diuretic does not affect blood pressure variability. Systolic blood pressure varies to a greater degree than diastolic blood pressure.
机译:系统评价通常可以揭示远远超出工作最初目标的内容。这项回顾性分析的目的是回答有关血压变异性的三个基本问题:1)血压输入标准是否对基线血压变异性有影响? 2)噻嗪类利尿剂对血压变异性有明显影响吗? 3)收缩压与舒张压的变化程度是否相同?这项对血压变异性的分析是基于静息的标准化研究设置,该数据来自两个系统评价对BP读数的评估,该评价来自双盲随机对照试验对33,611例原发性高血压患者的噻嗪类利尿剂降压效果。试验中报告的标准偏差是研究的重点和分析单位。当使用收缩压或舒张压阈值确定是否进入试验时,基线变异性显着降低,收缩压从14.0 mmHg降低到9.3 mmHg,舒张压从8.4 mmHg降低到5.3 mmHg。噻嗪类药物和安慰剂组在治疗结束时,噻嗪类药物不会改变BP变异性,因为标准偏差和收缩压和舒张压的变异系数没有差异。收缩压的变异系数显着大于舒张压的变异系数。进入标准可降低基线血压变异性。噻嗪类利尿剂治疗不会影响血压变异性。收缩压的变化幅度大于舒张压。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号